This in vitro study examined the effect of D-beta-hydroxybutyrate (BHB) on cellular models of Hutchinson-Gilford progeria syndrome (HGPS), which is caused by the aberrant protein progerin. BHB improved nuclear and nucleolar morphometrics, diminished the senescence phenotype, enhanced degradation of SQSTM1/p62 consistent with stimulated autophagic flux, and decreased progerin abundance. Inhibitors of AMPK and of ULK1/2 and AMPK reversed the BHB-induced progerin decline and its anti-senescent effect.
A goBHB specialist picks these up and answers inside one business day.